Evernorth, Transcarent team up for cancer care program

52 Views
Evernorth, Transcarent team up for cancer care program

Evernorth has tapped Transcarent to power its Oncology Benefit Services offering, which aims to offer end-to-end support for cancer patients for the course of their care journey.

The companies announced Thursday that the program is built on a digital platform that unites key cancer services across the patients’ medical and pharmacy benefits and connects them to a dedicated care team for personalized support and outreach.

This digital platform makes it easier for employers to offer a “streamlined” experience to workers, according to the announcement. Through it, members can reach dedicated oncology nurse navigators who have an American Cancer Society Leadership in Oncology Navigation (ACS LION) certification, find and schedule appointments with cancer centers of excellence, connect to virtual care or have key drug consultations.

Nurse navigators are also trained to provide support to the patients’ caregivers. They’re able to provide educational materials, assistance in appointment scheduling and answers to key questions.

“We are excited for this opportunity to work with Evernorth to deliver the most comprehensive, end-to-end care experience available anywhere for employees and their families,” said Glen Tullman, Chief Executive Officer at Transcarent, in a press release. “Transcarent and Evernorth share a commitment to making a meaningful difference in the lives of people impacted by cancer. Our partnership redefines the standard for cancer care delivery.” 

Members will also have access to critical pharmacy support through Evernorth’s Accredo and Express Scripts, according to the announcement. They can reach out to clinical experts with medication questions around the clock.

Transcarent first unveiled a cancer care program in April 2022. 

Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by lifecarefinanceguide.
Publisher: Source link


Leave a comment